BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7887989)

  • 1. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J; Winternitz F
    Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of [L-3,4-dehydroproline3]-tuftsin.
    Amoscato AA; Babcock GF; Nishioka K
    Peptides; 1984; 5(3):489-94. PubMed ID: 6548023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
    Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
    Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.
    Fridkin M; Stabinsky Y; Zakuth V; Spirer Z
    Biochim Biophys Acta; 1977 Jan; 496(1):203-11. PubMed ID: 576412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quenched molecular dynamics simulations of tuftsin and proposed cyclic analogues.
    O'Connor SD; Smith PE; al-Obeidi F; Pettitt BM
    J Med Chem; 1992 Jul; 35(15):2870-81. PubMed ID: 1495018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of human granulocyte phagocytosis stimulation by tuftsin.
    Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
    J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ; Słoń J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to some biochemical mechanisms of action of tuftsin and analogues.
    Kraus-Berthier L; Ferry G; Combe-Perez V; Visalli M; Remond G; Vincent M; Boutin JA
    Biochem Pharmacol; 1991 May; 41(10):1411-8. PubMed ID: 1850275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the peptide chain length of new elongated tuftsin analogs on phagocytosis process.
    Konopińska D; Kazanowska B; Bogusławska-Jaworska J
    Int J Pept Protein Res; 1984 Sep; 24(3):267-73. PubMed ID: 6594319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further investigations on the antinociceptive activity of tuftsin analogs.
    Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
    Gershonov E; Granoth R; Tzehoval E; Gaoni Y; Fridkin M
    J Med Chem; 1996 Nov; 39(24):4833-43. PubMed ID: 8941397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.